Hepatic microsomal UDP-glucuronosyltransferase (UGT) activities in the microminipig

Eriko Higashi1, Akihiro Ando, Shunsuke Iwano

  • 1Toxicology and Pharmacokinetics Laboratories, Pharmaceutical Research Laboratories, Toray Industries, Inc., 6-10-1 Tebiro, Kamakura, Kanagawa, 248-8555, Japan.

Insights

Microminipigs show distinct UDP-glucuronosyltransferase (UGT) activities, with higher estradiol and morphine glucuronidation than humans, aiding in selecting animal models for drug metabolism studies.

Area of Science:

  • Pharmacology and Toxicology
  • Drug Metabolism
  • Biochemistry

Background:

  • The microminipig is a novel animal model for nonclinical studies.
  • Understanding species differences in drug metabolism is crucial for interpreting study results.
  • UDP-glucuronosyltransferase (UGT) enzymes play a key role in the metabolism of many compounds.

Purpose of the Study:

  • To characterize hepatic UGT activity in microminipigs.
  • To compare microminipig UGT activity with that of humans and other animal models.
  • To provide data for selecting appropriate animal models in drug development.

Main Methods:

  • In vitro assessment of UGT activity using liver microsomes from microminipigs, humans, mice, rats, dogs, monkeys, and minipigs.
  • Measurement of glucuronidation of specific substrates (estradiol, imipramine, serotonin, propofol, AZT, morphine) using LC-MS/MS.
  • Analysis of UGT isoforms including human UGT1A1, 1A4, 1A6, 1A9, and 2B7.

Main Results:

  • Microminipigs exhibited higher estradiol-3-glucuronidation than humans and other species, particularly at 1 day old.
  • Imipramine-N-glucuronidation, characteristic of human UGT1A4, was observed in microminipigs but not dogs.
  • Morphine-3-glucuronidation was higher in microminipigs than in humans, while AZT-glucuronidation was lower.
  • Overall UGT activity profiles in microminipigs closely resembled those of minipigs.

Conclusions:

  • Microminipig hepatic UGT activity differs from humans, particularly in estradiol and morphine metabolism.
  • The findings highlight the importance of considering species-specific UGT profiles when selecting animal models for drug studies.
  • Microminipigs may serve as a valuable model for specific drug metabolism pathways, similar to minipigs.

Related Concept Videos

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
94
Phase II Reactions: Glucuronidation01:24

Phase II Reactions: Glucuronidation

Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
2.2K
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.7K
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
35